Why the study?
Does increasing the expression or activity of MICU1 ameliorate cardiomyopathy in diabetic mice?
Does increasing the expression or activity of MICU1 ameliorate cardiomyopathy in diabetic mice?
Increasing MICU1 expression or activity represents a potential pharmacological approach to ameliorate diabetic cardiomyopathy.
Hypothesis-generating in diabetic mice; leaves open MICU1 as a therapeutic target pending human studies.
mice, suggesting that increasing the expression or activity of MICU1 may be a pharmacological approach to ameliorate cardiomyopathy in diabetes.
No takes yet. Share an insight, caveat, or question.
Ji et al. (2017) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: